Top Markets
#1 Akedo Akedo +195.32%
#2 ONFA ONFA +54.15%
#3 Talus Network Talus Network +26.48%
#4 0G 0G +21.23%
#5 Osaka Protocol Osaka Protocol +20.92%
#6 Metaplex Metaplex +20.26%
#7 Wrapped Krown Wrapped Krown +19.97%
#8 EVAA Protocol EVAA Protocol +18.16%
#9 eCash eCash +15.89%
#10 Unibase Unibase +15.04%
Coin of the day
Akedo Akedo
Einstellungen
Sprache
DEUTSCH
Währung
USD
Thema
Pfizer Inc. Pfizer Inc.

Pfizer Inc.

PFE
Rang in Aktien #146
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells... Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Aktienkurs
$24.25
Marktkapitalisierung
$138.21B
Veränderung (1 Tag)
-0.94%
Veränderung (1 Jahr)
194.85%
Land
US
Handel Pfizer Inc. (PFE)

Kategorie

Healthcare
Gewinn für Pfizer Inc. (PFE)
Gewinn im 2026 TTM: 0
Laut den aktuellen Finanzberichten von Pfizer Inc. betragen die aktuellen Gewinne des Unternehmens 0. Im Jahr 2026 erzielte das Unternehmen einen Gewinn von 0, gleich wie dem Gewinn im Jahr 2026, der 0 betrug. Die auf dieser Seite angezeigten Gewinne sind die Gewinne vor Zinsen und Steuern, auch bekannt als EBIT.
Gewinnverlauf von Pfizer Inc. von 2026 bis 2026
Gewinn am Ende jedes Jahres
Jahr Gewinn ändert
Nicht genügend Daten für die angegebenen Daten.
Gewinn ähnlicher Unternehmen oder Konkurrenten
Unternehmen Gewinn Gewinnunterschied Land
Eli Lilly Eli Lilly
Eli Lilly
LLY.US
$31.12B -
US
Johnson & Johnson Johnson & Johnson
Johnson & Johnson
JNJ.US
$24.94B -
US
AbbVie Inc. AbbVie Inc.
AbbVie Inc.
ABBV.US
$5.98B -
US
Merck & Co., Inc. Merck & Co., Inc.
Merck & Co., Inc.
MRK.US
$11.63B -
US
Novartis AG Novartis AG
Novartis AG
NVS.US
$15.78B -
CH